Hemochromatosis
Showing 1 - 25 of 132
Hemochromatosis Trial run by the National Institutes of Health Clinical Center (CC) (Phlebotomy)
Recruiting
- Hemochromatosis
- Phlebotomy
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 30, 2023
Cardiac Function in Patients With Hereditary Hemochromatosis
Completed
- Hereditary Hemochromatosis
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 27, 2023
"Iron Overload and Endocrinological Diseases"
Recruiting
- Iron Overload
- +4 more
-
Modena, ItalyUnit of Endocrinology of Azienza Ospedaliero-Universitaria di Mo
Nov 13, 2023
Hereditary Hemochromatosis, Hyperferritinemia Trial in Basel, Berne (Venipuncture)
Enrolling by invitation
- Hereditary Hemochromatosis
- Hyperferritinemia
- Venipuncture
-
Basel, Switzerland
- +1 more
Feb 14, 2023
MRI QSM Imaging for Iron Overload
Recruiting
- Hemochromatosis
- Iron Overload
- Magnetic Resonance Imaging (MRI)-based Quantitative Susceptibility Mapping (QSM)
-
Stanford, California
- +1 more
Aug 2, 2022
Hereditary Hemochromatosis Trial in Melbourne (BBI-001, Original Fibre Metamucil)
Recruiting
- Hereditary Hemochromatosis
- BBI-001
- Original Fibre Metamucil
-
Melbourne, Victoria, AustraliaNucleus Networks
Jul 18, 2022
Idiopathic Pulmonary Hemosiderosis, Leflunomide Trial in Guangzhou (Leflunomide, Steroid Drug)
Recruiting
- Idiopathic Pulmonary Hemosiderosis
- Leflunomide
- Leflunomide
- Steroid Drug
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital of Sun Yat-sen University
Jun 30, 2023
Iron Deficiency Anemia of Pregnancy, Iron Storage Disease Trial in Jinan (Niferex)
Recruiting
- Iron Deficiency Anemia of Pregnancy
- Iron Storage Disease
-
Jinan, Shandong, ChinaShandong Provincial Qianfoshan Hospital
Apr 6, 2023
Hemochromatosis Type 1 Trial in Rennes (First evaluation phase : no intervention / Second evaluation phase: bloodletting of 7
Completed
- Hemochromatosis Type 1
- First evaluation phase : no intervention / Second evaluation phase: bloodletting of 7 ml/kg (with a maximum of 500ml)
-
Rennes, FranceCHU Pontchaillou
Jun 8, 2021
Iron Deposits in Pancreas by MRI Method of Dialysis
Not yet recruiting
- Iron Deposition
- +2 more
- MRI
-
Quincy-sous-Sénart, FranceHôpital Privé Claude Galien
Oct 20, 2022
World Mosquito Program Noumea - Human Sample Component
Recruiting
- Arbovirus Infections
- Blood donations of hemochromatosis or polycythemia patients
- Blood donations of healthy donors
-
Nouméa, Nouvelle-Calédonie, FranceCentre Hospitalier de Nouvelle-Calédonie
Feb 14, 2022
Nonalcoholic Fatty Liver Disease (NAFLD) Pediatric Patients
Completed
- Steatohepatitis, Nonalcoholic
- +4 more
-
Fort Sam Houston, TexasBrooke Army Medical Center
Mar 21, 2022
Haemochromatosis Trial in France (other, biological, procedure)
Recruiting
- Haemochromatosis
- Clinical examination
- +14 more
-
Bobigny, France
- +10 more
Jul 13, 2021
Deferoxamine for the Treatment of Hemochromatosis
Completed
- Diabetes Mellitus
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 11, 2019
Transferrin Saturation and Asthenia in Hemochromatosis
Completed
- Hemochromatoses, Genetic
-
Rennes, Britain, FranceRennes University Hospital
Jul 30, 2019
Non-invasive Quantification of Liver Iron With MRI
Completed
- Iron Overload
- Hemosiderosis
- Non-contrast MRI
-
Madison, WisconsinWisconsin Institutes for Medical Research
Dec 4, 2019
Cirrhotic Patients With and Without Hepatocellular Carcinoma
Not yet recruiting
- Pulmonary Complications of Liver Cirrhosis and HCC
- spirometry
-
Sohag, EgyptSohag University hospitals
Jul 26, 2023
Key Diagnosis and Treatment Technology of Genetic and Metabolic
Not yet recruiting
- Diagnosis , Treatment, Genetic and Metabolic Liver Disease
- There is no intervention
- (no location specified)
Oct 27, 2022
Dysmetabolic Iron Overload Syndrome, Genetic Hemochromatosis, Iron Absorption Trial in Clermont-Ferrand (polyphenols, Placebo)
Completed
- Dysmetabolic Iron Overload Syndrome
- +3 more
- polyphenols
- Placebo
-
Clermont-Ferrand, FranceCHU Clermont-Ferrand
Mar 29, 2019
Evaluation of Patients With Liver Disease
Recruiting
- Hepatitis D
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Fabry Disease Trial in Bron, Lyon (T1 mapping measurement)
Not yet recruiting
- Fabry Disease
- T1 mapping measurement
-
Bron, France
- +1 more
Jun 27, 2023
Transfusion-dependent Hemachromatosis, Thalassemia Major, Sickle Cell Disease Trial in Boston (Deferoxamine, Deferasirox, HIDA)
Completed
- Transfusion-dependent Hemachromatosis
- +2 more
- Deferoxamine
- +2 more
-
Boston, MassachusettsChildren's Hospital Boston
Jun 14, 2019
Breast Tumor Female, Metastatic Breast Cancer Trial in Olomouc (Disulfiram)
Recruiting
- Breast Neoplasm Female
- Metastatic Breast Cancer
-
Olomouc, CzechiaUniversity Hospital Olomouc
Aug 2, 2022